Aurobindo Pharma USA Inc. is recalling 2,352 bottles of Simvastatin (simvastatin) 40 mg tablets because some 1,000-count bottles were printed with the incorrect lot number. Affected bottles are labeled with lot number 05318054B instead of the correct number, 05318034B. This medication, used to treat high cholesterol, was distributed nationwide to major distributors. If you have a bottle of this medication, you should verify the lot number on the label immediately.
Incorrect lot numbers on prescription medication labels can prevent healthcare providers and consumers from identifying products during safety events or quality concerns. While the medication itself is not defective, inaccurate labeling compromises the ability to track and manage the product's safety history.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.